{
  "case_id": "case_0005",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 41.05,
    "sex": "Female",
    "genderIdentity": "Cisgender Male",
    "ancestry": "Sub-Saharan African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- right cerebellum and left optic nerve (cranial nerve II).",
      "structured_data": {
        "gt_lesions_english": [
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "Cerebellar Hemisphere",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "Optic Nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD); Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (AQP4-NMOSD); Neurosarcoidosis; Autoimmune/Paraneoplastic Cerebellar Degeneration; Cerebellar Infarction with unrelated Optic Neuritis; Vitamin B12 Deficiency",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing-remitting Multiple Sclerosis",
          "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)",
          "Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (AQP4-NMOSD)",
          "Neurosarcoidosis",
          "Autoimmune/Paraneoplastic Cerebellar Degeneration",
          "Cerebellar Infarction with unrelated Optic Neuritis",
          "Vitamin B12 Deficiency"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Pelvic pain": "comorbidity",
          "Nightmares": "comorbidity",
          "Hypercholesterolaemia": "comorbidity",
          "Rosacea": "comorbidity",
          "Fibroids": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Pelvic pain",
          "Nightmares",
          "Hypercholesterolaemia",
          "Rosacea",
          "Fibroids"
        ],
        "additional_diagnoses": [
          "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)",
          "Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (AQP4-NMOSD)",
          "Neurosarcoidosis",
          "Autoimmune/Paraneoplastic Cerebellar Degeneration",
          "Cerebellar Infarction with unrelated Optic Neuritis",
          "Vitamin B12 Deficiency"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Brain and Orbits and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and orbits with gadolinium (including DWI and dedicated optic nerve sequences)",
          "MRI of cervical and thoracic spine with gadolinium",
          "Visual evoked potentials",
          "Optical coherence tomography of retinal nerve fibre layer",
          "Lumbar puncture: CSF cell count and differential",
          "CSF protein",
          "CSF glucose",
          "CSF oligoclonal bands",
          "CSF IgG index",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Thyroid function tests",
          "Vitamin B12",
          "Folate",
          "25-hydroxy vitamin D",
          "Serum ACE",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Double-stranded DNA antibody",
          "ANCA",
          "HIV serology",
          "Syphilis serology (RPR/TPPA)",
          "Lyme serology",
          "Aquaporin-4 IgG (serum cell-based assay)",
          "MOG IgG (serum cell-based assay)",
          "Urinalysis and urine culture (exclude infection before steroids)",
          "Pregnancy test",
          "Hepatitis B surface antigen",
          "Hepatitis B core antibody",
          "Hepatitis C antibody",
          "QuantiFERON-TB Gold"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 3,
        "found_tests_count": 3,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Unsafe decision to start treatment now.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication whether this is related to MS.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days (or oral equivalent 1 g)",
            "timing": "Start Now",
            "reasons": [
              "Functionally significant acute relapse (optic neuritis with ataxia)",
              "Early steroids shorten time to neurological recovery",
              "Low risk when infection is excluded"
            ]
          },
          {
            "treatment": "Proton pump inhibitor and capillary glucose monitoring during steroids",
            "timing": "Start Now",
            "reasons": [
              "Gastroprotection and metabolic safety with high-dose steroids"
            ]
          },
          {
            "treatment": "Physiotherapy and falls-prevention gait training",
            "timing": "Start Now",
            "reasons": [
              "Cerebellar ataxia increases fall risk",
              "Early rehab improves function"
            ]
          },
          {
            "treatment": "Plasma exchange (5\u20137 exchanges) if poor response to steroids",
            "timing": "Delay",
            "reasons": [
              "Second-line for steroid-refractory optic neuritis/cerebellar relapse",
              "Initiate if no improvement within 5\u20137 days"
            ]
          },
          {
            "treatment": "Initiate disease-modifying therapy for multiple sclerosis (e.g., ocrelizumab) after confirmation",
            "timing": "Delay",
            "reasons": [
              "Requires diagnostic confirmation and safety screening",
              "Prevents future relapses and disability accrual"
            ]
          },
          {
            "treatment": "Long-term immunotherapy for AQP4-positive NMOSD (e.g., rituximab or satralizumab) if confirmed",
            "timing": "Delay",
            "reasons": [
              "Choice depends on antibody status",
              "Start after results and counselling"
            ]
          },
          {
            "treatment": "Vitamin D supplementation",
            "timing": "Delay",
            "reasons": [
              "Begin if level is low",
              "Potential disease-modifying benefit in demyelination"
            ]
          },
          {
            "treatment": "Vaccination review and avoidance of live vaccines before immunotherapy",
            "timing": "Delay",
            "reasons": [
              "Immunisation optimisation reduces infection risk with future DMTs"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days (or oral equivalent 1 g)",
            "timing": "Start Now",
            "reasons": [
              "Functionally significant acute relapse (optic neuritis with ataxia)",
              "Early steroids shorten time to neurological recovery",
              "Low risk when infection is excluded"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint is not specified, so no indication whether this is related to MS.",
                "Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Unsafe decision to start treatment now.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication whether this is related to MS.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Initiate disease-modifying therapy for multiple sclerosis (e.g., ocrelizumab) after confirmation",
            "timing": "Delay",
            "reasons": [
              "Requires diagnostic confirmation and safety screening",
              "Prevents future relapses and disability accrual"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 1,
          "gt_reasons_count": 4,
          "acknowledged_reasons_count": 1,
          "missed_reasons_count": 3,
          "proportion_reasons_acknowledged": 0.25,
          "proportion_reasons_missed": 0.75
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 4,
          "acknowledged_reasons_count": 3,
          "missed_reasons_count": 1,
          "proportion_reasons_acknowledged": 0.75,
          "proportion_reasons_missed": 0.25
        }
      }
    }
  }
}